CD209 and infectious disease: The utilization of DC-SIGN in such an orthogonal set of virus–host interactions has been investigated in other infectious diseases, leading to a broadening of perspectives as to how pathogens can subvert host immune responses via pathogen carbohydrate binding by host lectins, especially CTLs.